DOAJ Open Access 2025

Structural and virological identification of neutralizing antibody footprint provides insights into therapeutic antibody design against SARS-CoV-2 variants

Yuki Anraku Shunsuke Kita Taishi Onodera Akihiko Sato Takashi Tadokoro +20 lainnya

Abstrak

Abstract Medical treatments using potent neutralizing SARS-CoV-2 antibodies have achieved remarkable improvements in clinical symptoms, changing the situation for the severity of COVID-19 patients. We previously reported an antibody, NT-108 with potent neutralizing activity. However, the structural and functional basis for the neutralizing activity of NT-108 has not yet been understood. Here, we demonstrated the therapeutic effects of NT-108 in a hamster model and its protective effects at low doses. Furthermore, we determined the cryo-EM structure of NT-108 in complex with SARS-CoV-2 spike. The single-chain Fv construction of NT-108 improved the cryo-EM maps because of the prevention of preferred orientations induced by Fab orientation. The footprints of NT-108 illuminated how escape mutations such as E484K evade from class 2 antibody recognition without ACE2 affinity attenuation. The functional and structural basis for the potent neutralizing activity of NT-108 provides insights into the rational design of therapeutic antibodies.

Topik & Kata Kunci

Penulis (25)

Y

Yuki Anraku

S

Shunsuke Kita

T

Taishi Onodera

A

Akihiko Sato

T

Takashi Tadokoro

S

Shiori Ito

Y

Yu Adachi

R

Ryutaro Kotaki

T

Tateki Suzuki

J

Jiei Sasaki

N

Nozomi Shiwa-Sudo

N

Naoko Iwata-Yoshikawa

N

Noriyo Nagata

S

Souta Kobayashi

Y

Yasuhiro Kazuki

M

Mitsuo Oshimura

T

Takao Nomura

M

Michihito Sasaki

Y

Yasuko Orba

T

Tadaki Suzuki

H

Hirofumi Sawa

T

Takao Hashiguchi

H

Hideo Fukuhara

Y

Yoshimasa Takahashi

K

Katsumi Maenaka

Format Sitasi

Anraku, Y., Kita, S., Onodera, T., Sato, A., Tadokoro, T., Ito, S. et al. (2025). Structural and virological identification of neutralizing antibody footprint provides insights into therapeutic antibody design against SARS-CoV-2 variants. https://doi.org/10.1038/s42003-025-07827-0

Akses Cepat

PDF tidak tersedia langsung

Cek di sumber asli →
Lihat di Sumber doi.org/10.1038/s42003-025-07827-0
Informasi Jurnal
Tahun Terbit
2025
Sumber Database
DOAJ
DOI
10.1038/s42003-025-07827-0
Akses
Open Access ✓